Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L
Clinical trial NCT00807599 · COMPLETED
Trial details
- NCT number
- NCT00807599
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-10
- Primary completion
- 2018-07-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.